TY - JOUR
T1 - EEG with extreme delta brush in young female with methotrexate neurotoxicity supports NMDA receptor involvement
AU - Schmidt, Lisbeth Samsø
AU - Kjær, Troels W
AU - Schmiegelow, Kjeld
AU - Born, Alfred Peter
N1 - Copyright © 2017 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
PY - 2017/9
Y1 - 2017/9
N2 - Sub-acute neurotoxicity is a well-known complication to high-dose and intrathecal methotrexate (MTX) treatment of children with leukemia. Symptoms can be treated safely by dextromethorphan, a non-competitive antagonist to N-methyl-D-aspartic acid receptor (NMDAR). In a female with subacute MTX neurotoxicity, we observed an electroencephalographic (EEG) with extreme delta brush. Extreme delta brush is an EEG pattern previously described in patients with NMDAR autoimmune encephalitis. The observations suggest that the mechanism of this neurotoxicity may be mediated by the NMDAR. Furthermore, extreme EEG delta brush should suggest a diagnosis of MTX associated subacute neurotoxicity.
AB - Sub-acute neurotoxicity is a well-known complication to high-dose and intrathecal methotrexate (MTX) treatment of children with leukemia. Symptoms can be treated safely by dextromethorphan, a non-competitive antagonist to N-methyl-D-aspartic acid receptor (NMDAR). In a female with subacute MTX neurotoxicity, we observed an electroencephalographic (EEG) with extreme delta brush. Extreme delta brush is an EEG pattern previously described in patients with NMDAR autoimmune encephalitis. The observations suggest that the mechanism of this neurotoxicity may be mediated by the NMDAR. Furthermore, extreme EEG delta brush should suggest a diagnosis of MTX associated subacute neurotoxicity.
KW - Adolescent
KW - Anti-N-Methyl-D-Aspartate Receptor Encephalitis/chemically induced
KW - Antimetabolites, Antineoplastic/adverse effects
KW - Dextromethorphan/therapeutic use
KW - Electroencephalography
KW - Female
KW - Humans
KW - Methotrexate/adverse effects
KW - Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors
U2 - 10.1016/j.ejpn.2017.05.008
DO - 10.1016/j.ejpn.2017.05.008
M3 - Journal article
C2 - 28655493
SN - 1090-3798
VL - 21
SP - 795
EP - 797
JO - European Journal of Paediatric Neurology
JF - European Journal of Paediatric Neurology
IS - 5
ER -